Home » Topics » BioWorld

BioWorld
RSS

ONCOGENE, APPLIED BIOTECH TEAM TO FIGHT CANCER

May 23, 1991

AGRACETUS GETS PATENT TO TRANSFORM SOYBEANS

May 22, 1991

BIOGEN TO REDEEM PREFERRED STOCK

May 22, 1991

EC RECOMMENDS INTRON A APPROVAL

May 22, 1991

CETUS STOCK RISES AFTER IL-2 PREDICTION

May 22, 1991

CAMBRIDGE BIO TO TEST MALARIA VACCINES

May 22, 1991

TRANSKARYOTIC NAMES PRESIDENT

May 22, 1991

BTGC RAISES $5.7 MILLION IN PRIVATE PLACEMENT

May 22, 1991

COLLAGEN PEPTIDE FOR BONE AND TISSUE REPAIR

May 22, 1991

APPOINTMENTS AND ADVANCEMENTS

May 21, 1991

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.